Confluent Medical Technologies expands Costa Rica facility for Nitinol and catheter manufacturing

Confluent Medical Technologies announced a significant expansion of its Costa Rica manufacturing with a new 67,000 sq. ft. facility to increase capacity for Nitinol processing and complex catheter production. The facility is expected to be operational in the first quarter of 2022.

“This expansion will support our new product pipeline that is significantly stronger than anything Confluent has previously experienced.”businesswire.com

• 1 source
• businesswire.comConfluent Medical Technologies Expanding, Adding Capacity for Nitinol Processing and Catheter ManufacturingMay 24, 2021

Summarized from public sources; check the original articles before acting on it.